Status:
COMPLETED
Cologne Esophageal Response Prediction Study (CERP-Study)
Lead Sponsor:
Elfriede Bollschweiler
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: The prognosis of patients with advanced esophageal cancer may be improved by preoperative chemoradiation. But only those patients have a benefit from this additional therapy, whose tumor sh...
Eligibility Criteria
Inclusion
- informed consent
- newly diagnosed adenocarcinoma or squamous cell carcinoma of the esophagus or cardia
Exclusion
- missing informed consent
- prior radiation or chemotherapy
- second malignancy
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00953511
Start Date
August 1 2009
End Date
August 1 2015
Last Update
October 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General, Visceral and Cancer Surgery, University of Cologne
Cologne, North Rhine-Westphalia, Germany, 50924